1. Home
  2. SLGL vs GTIM Comparison

SLGL vs GTIM Comparison

Compare SLGL & GTIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLGL
  • GTIM
  • Stock Information
  • Founded
  • SLGL 1997
  • GTIM 1987
  • Country
  • SLGL Israel
  • GTIM United States
  • Employees
  • SLGL N/A
  • GTIM 2110
  • Industry
  • SLGL Biotechnology: Pharmaceutical Preparations
  • GTIM Restaurants
  • Sector
  • SLGL Health Care
  • GTIM Consumer Discretionary
  • Exchange
  • SLGL Nasdaq
  • GTIM Nasdaq
  • Market Cap
  • SLGL 21.1M
  • GTIM 17.1M
  • IPO Year
  • SLGL 2018
  • GTIM 1990
  • Fundamental
  • Price
  • SLGL $7.24
  • GTIM $1.64
  • Analyst Decision
  • SLGL Buy
  • GTIM
  • Analyst Count
  • SLGL 1
  • GTIM 0
  • Target Price
  • SLGL $40.00
  • GTIM N/A
  • AVG Volume (30 Days)
  • SLGL 13.2K
  • GTIM 18.1K
  • Earning Date
  • SLGL 05-23-2025
  • GTIM 07-31-2025
  • Dividend Yield
  • SLGL N/A
  • GTIM N/A
  • EPS Growth
  • SLGL N/A
  • GTIM 65.30
  • EPS
  • SLGL N/A
  • GTIM 0.09
  • Revenue
  • SLGL $12,103,000.00
  • GTIM $144,322,000.00
  • Revenue This Year
  • SLGL N/A
  • GTIM N/A
  • Revenue Next Year
  • SLGL $31.17
  • GTIM N/A
  • P/E Ratio
  • SLGL N/A
  • GTIM $17.56
  • Revenue Growth
  • SLGL 603.66
  • GTIM 4.14
  • 52 Week Low
  • SLGL $3.34
  • GTIM $1.51
  • 52 Week High
  • SLGL $16.50
  • GTIM $3.45
  • Technical
  • Relative Strength Index (RSI)
  • SLGL 50.26
  • GTIM 42.55
  • Support Level
  • SLGL $7.15
  • GTIM $1.56
  • Resistance Level
  • SLGL $7.45
  • GTIM $1.72
  • Average True Range (ATR)
  • SLGL 0.32
  • GTIM 0.08
  • MACD
  • SLGL -0.10
  • GTIM 0.02
  • Stochastic Oscillator
  • SLGL 31.36
  • GTIM 61.90

About SLGL Sol-Gel Technologies Ltd.

Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includes SGT-610 (Patidegib Gel 2%), a new chemical entity hedgehog signaling pathway blocker, for the chronic use and prevention of new BCC in Gorlin syndrome patients, and the topical drug candidate SGT-210 for the treatment of Darier Disease and other rare keratosis-related indications such as PC, PPK and Olmsted.

About GTIM Good Times Restaurants Inc.

Good Times Restaurants Inc is engaged in developing, owning, operating, and franchising hamburger-oriented drive-through restaurants. It operates through two segments: Good Times Burgers and Frozen Custard restaurants which operate in the quick-service drive-through dining industry; and Bad Daddy's Burger Bar restaurants which operate in the full-service upscale casual dining industry. The company generates maximum revenue from the Bad Daddy's Burger Bar restaurants segment. Its menu categories include burgers; chicken; frozen custard; slides and drinks.

Share on Social Networks: